Aggregated News From Investment Management Regulators

Press release on the reopening of trading in Acacia Pharma

Report/Flag

Please complete the required fields.



ANNOUNCEMENT BY THE FINANCIAL SERVICES AND MARKETS AUTHORITY, PUBLISHED IN APPLICATION OF ARTICLE 78 OF THE LAW OF 21 NOVEMBER 2017

Trading in the financial instruments of Acacia Pharma, ISIN GB00BYWF9Y76, on Euronext Brussels will re-open on 14-08-2020 at 9:00 CET.

Source link

Regulator Information

Abbreviation: FSMA
Jurisdiction: Belgium

Recent Articles

The AMF presents an initial overview of SFTR reporting data

Based on the recommendations of the Financial Stability Board, the European Securities Financing Transactions Regulation (SFTR), enacted in November 2015, has made it possible to establish greater tr

SEC Issues Whistleblower Awards Totaling Nearly $5.3 Million

The Securities and Exchange Commission today announced awards of nearly $5.3 million to whistleblowers who provided information and assistance in separate enforcement proceedings.

HQ Trade

We believe this firm may be providing financial services or products in the UK without our authorisation. Find out why you should be wary...

searchinvestments-uk.com

We believe this firm may be providing financial services or products in the UK without our authorisation. Find out why you should be wary...

highestfixedrates.com

We believe this firm may be providing financial services or products in the UK without our authorisation. Find out why you should be wary...

Get the latest from Regulatory.News in your inbox!

×